Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2013
09/26/2013WO2013142370A1 APP SPECIFIC BACE INHIBITORS (ASBIs) AND USES THEREOF
09/26/2013WO2013142369A1 Treatment of pulmonary hypertension with leukotriene inhibitors
09/26/2013WO2013142359A1 Method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration
09/26/2013WO2013142358A1 Formulations of bendamustine
09/26/2013WO2013142346A1 Premature-termination-codons readthrough compounds
09/26/2013WO2013142328A1 Small molecule antagonists of pf4 containing ultra large complexes
09/26/2013WO2013142326A1 5-carbonylamino-/(sulfonamido-) substituted benz imidazoles and use thereof treatment of tuberculosis
09/26/2013WO2013142307A1 Carbamate compounds and of making and using same
09/26/2013WO2013142281A1 Inhibition of mcl-1 and/or bfl-1/a1
09/26/2013WO2013142274A1 Extended-release formulation for reducing the frequency of urination and method of use thereof
09/26/2013WO2013142269A1 Imidazotriazinone compounds
09/26/2013WO2013142266A1 Estrogen receptor modulators and uses thereof
09/26/2013WO2013142258A1 Compositions and methods for oral delivery of encapsulated diethylenetriaminepentaacetate particles
09/26/2013WO2013142247A1 Cyclodextrin-based microemulsions, and dermatological uses thereof
09/26/2013WO2013142236A1 Compounds for treating spinal muscular atrophy
09/26/2013WO2013142214A1 Compounds and methods for treating aberrant adrenocartical cell disorders
09/26/2013WO2013142205A1 Pharmaceutical compositions comprising benzyl alcohol
09/26/2013WO2013142202A1 Pharmaceutical compositions comprising glycerol esters
09/26/2013WO2013142198A1 Pharmaaceutical compositions comprising fatty acid esters
09/26/2013WO2013142197A1 Extended-release formulation for reducing the frequency of urination and method of use thereof
09/26/2013WO2013142184A1 Antimicrobial compositions and methods
09/26/2013WO2013142162A1 Method of treating bladder disorders
09/26/2013WO2013142159A1 Pharmaceutical combinations comprising a thionucleotide analog
09/26/2013WO2013142157A1 Pharmaceutical combinations comprising a thionucleotide analog
09/26/2013WO2013142152A1 Semi-solid delivery systems
09/26/2013WO2013142142A1 Natural saponin-based synthetic immunoadjuvants
09/26/2013WO2013142124A1 Solid forms of a thiophosphoramidate nucleotide prodrug
09/26/2013WO2013142010A1 3-AMINOTHIENO[3,2-c]QUINOLINE DERIVATIVES, METHODS OF PREPARATION AND USES
09/26/2013WO2013141827A1 Enteric coated solid pharmaceutical compositions for proton pump inhibitors
09/26/2013WO2013141758A1 Pharmaceutical composition having neuroprotective, antiamnesic, antioxidant, antihypoxic, neurometabolic and anti-ischemic activity (variants)
09/26/2013WO2013141723A1 Preparation of pectin and polyphenolic compositions from mango peels
09/26/2013WO2013141586A1 Novelpyridopyrimidine derivatives and use thereof
09/26/2013WO2013141576A1 Method for stabilizing ramalin using porous matrix, and stablized ramalin solution
09/26/2013WO2013141575A1 Material for preventing or treating asthma and derivatives thereof
09/26/2013WO2013141565A1 Composition for enhancing defenses of skin
09/26/2013WO2013141437A1 Method for manufacturing high purity (s)-metoprolol
09/26/2013WO2013141346A1 Method for producing liposome encapsulating paclitaxel monoglycoside and/or docetaxel monoglycoside
09/26/2013WO2013141267A1 Polyphenol stabilizer, and composition and processed goods containing said stabilizer
09/26/2013WO2013141264A1 Novel cysteine compound and salt thereof
09/26/2013WO2013141202A1 Muscle-building agent and screening method for muscle-building substance
09/26/2013WO2013141092A1 Cancer metastasis marker and method for diagnosing cancer metastasis using same
09/26/2013WO2013140799A1 Transdermal absorption preparation
09/26/2013WO2013140417A1 BORONIC ACID BEARING LIPHAGANE COMPOUNDS AS INHIBITORS OF PI3K-α AND/OR β
09/26/2013WO2013140372A1 Method for treating gynecological diseases
09/26/2013WO2013140348A1 Compounds for the treatment of ischemia-reperfusion- related diseases
09/26/2013WO2013140347A1 Sulphonamide derivatives of benzylamine for the treatment of cns diseases
09/26/2013WO2013140342A1 Treatment of schizophrenia using beta-caryophyllene and cb2 receptor agonists
09/26/2013WO2013140319A1 Crystalline form of a succinate salt
09/26/2013WO2013140232A1 An improved process for the preparation of sunitinib and its acid addition salts thereof
09/26/2013WO2013140189A1 6- (4- (1 -amino- 3 -hydroxycyclobutyl) phenyl) - 5 - phenyl (furo, thieno or pyrrolo) [2, 3-d] pyrimidin- 4 - one derivatives for the treatment of cancer
09/26/2013WO2013140170A1 Treatment of microbial infections
09/26/2013WO2013140148A1 Quinazoline compounds and their use in therapy
09/26/2013WO2013140120A1 Glycerol solvate forms of (r) - 2 - [ [ [3 -methyl -4 (2,2, 2 - trifluoroethoxy) pyridin- 2 - yl] methyl] sulphinyl] - 1h - ben zimidazole
09/26/2013WO2013139991A1 Pharmaceutical formulation comprising bendamustine
09/26/2013WO2013139941A1 Pharmaceutical combination products for parkinson's disease
09/26/2013WO2013139940A1 Novel therapeutic target for the prevention of tumour metastasis
09/26/2013WO2013139931A1 Composition for use in the treatment of neurodegenerative diseases with parkinsonian syndromes
09/26/2013WO2013139929A1 Novel means and methods for treating diseases of the central nervous system, metabolic and cardiac diseases and aging
09/26/2013WO2013139927A1 Composition for the treatment of pediculosis and corresponding manufacturing process
09/26/2013WO2013139918A1 Topical application of ingenol mebutate with occlusion
09/26/2013WO2013139882A1 Pyrazolopyridines for treatment of parkinsons disease
09/26/2013WO2013139861A1 Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders
09/26/2013WO2013139826A1 Pharmaceutical compositions comprising imatinib
09/26/2013WO2013139822A1 Novel bisoxime microbiocides
09/26/2013WO2013139809A1 Use of a pyrazole derivative in the treatment of acute exacerbations of chronic obstructive pulmonary disease
09/26/2013WO2013139796A1 Use of amphoteric surfactants for the prevention and treatment of pathogenic vaginal biofilms in vaginal infections
09/26/2013WO2013139777A1 Pharmaceutical composition comprising empagliflozin and antiobesity drug
09/26/2013WO2013139734A1 Use of (rs)-s-cyclopropyl-s-(4-{[4-{[1r, 2r)-2-hydroxy-1-methylpropyl]oxy}-5-(trifluoromethyl)pyrimidin-2-yl]amino}phenyl)sulfoximide for treating specific tumours
09/26/2013WO2013139730A1 Chemical compounds
09/26/2013WO2013139727A1 Triazines with suitable spacers for treatment and/or prevention of hiv infections
09/26/2013WO2013139724A1 Combination therapy (vemrufenib and a mdm2 inhibitor) for the treatment proliferative disorders
09/26/2013WO2013139712A1 NOVEL POLYMORPHIC CRYSTAL FORMS OF 5-(2-{[6-(2,2-DIFLUORO-2-PHENYLETHOXY)HEXYL]AMINO}-1-(R)-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE, HEMINAPADISYLATE AS AGONIST OF THE β2 ADRENERGIC RECEPTOR.
09/26/2013WO2013139700A1 Memory genes
09/26/2013WO2013139697A1 Conformationally constrained, fully synthetic macrocyclic compounds
09/26/2013WO2013139687A1 Method for administration of an anti tumor agent
09/26/2013WO2013139657A1 A mixture of polar glycolipids for use in the treatment of pain and copd
09/26/2013WO2013139487A1 Flavone derivatives and their use
09/26/2013WO2013139423A1 Combination of a 6-oxo-1,6-dihydro-pyridazine derivative having anti-cancer activity with other anti-tumor compounds
09/26/2013WO2013139387A1 Stabilized pharmaceutical compositions comprising rasagiline salts
09/26/2013WO2013139377A1 Method for producing enteric alginate microcapsules via ionic gelation containing diclofenac or one of the salts thereof and multiparticled pharmaceutical composition containing them
09/26/2013WO2013139341A1 Gpr120 receptor modulators
09/26/2013WO2013139292A1 Joint product containing synephrine and topiramate
09/26/2013WO2013139274A1 Sodium pyruvate oral rehydration salt composition for treating hypovolemia or hyponatration associated with hypohydration
09/26/2013WO2013139266A1 Joint product containing phentermine and topiramate and preparation method therefor
09/26/2013WO2013139209A1 Topiramate sustained-release pharmaceutical composition, method for preparing same, and use thereof
09/26/2013WO2013139206A1 3-oxo-3,4-dihydro-2-pyrazine-formamide derivative, pharmaceutical composition of same, method for preparing same, and use thereof
09/26/2013WO2013139195A1 Huperzine a polycrystal, preparation method therefor, pharmaceutical composition comprising polycrystal and use thereof
09/26/2013WO2013139179A1 Tigecycline composition for injection
09/26/2013WO2013139143A1 Salfaprodil crystal form, preparation method, and sterile powder containing salfaprodil crystal
09/26/2013WO2013138964A1 Application of iso-daphnetin compound in preparation of anti-diabetic medicines
09/26/2013WO2013138951A1 Quinazoline derivate and use thereof as apoptosis inhibitor
09/26/2013WO2013138930A1 Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivo
09/26/2013WO2013138863A1 Kinase inhibitors for the treatment of cancer
09/26/2013WO2013138860A1 Antibacterial compounds
09/26/2013WO2013116798A3 A method for the treatment and/or prevention of oral allergic symptoms of the lips due to oral contact with a food allergen
09/26/2013WO2013109388A8 1,5-naphthyridine derivatives and melk inhibitors containing the same
09/26/2013WO2013100822A3 Hemostimulating agent
09/26/2013WO2013090732A3 Collateral gene inactivation biomarkers and targets for cancer therapy
09/26/2013WO2013082469A3 Methods and compositions for treating infections
09/26/2013WO2013072390A3 Stilbene compounds as ppar beta/delta inhibitors for treating ppar beta/delta transmitted illnesses
1 ... 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 ... 7860